Our client UPMC announced a groundbreaking clinical trial using various mixes of drugs and utilizing artificial intelligence to quickly find the most effective medicine to address COVID-19. It is the result of UPMC leading an international discussion of this approach to drug trials and the UPMC designed trial will be undertaken at UPMC and simultaneously in 13 other countries. It could yield useful results in weeks or months, not years.
To view recent media, see links below:
- Physician Interviews
- Pittsburgh COVID-19 Press Briefing – April 9, 2020 – Dr. Derek C. Angus and Dr. Donald Yealy
- Tribune Review | By: Jamie Martines – UPMC launches trials of coronavirus drugs, including hydroxychloroquine
- Pittsburgh Post-Gazette | By: David Templeton – Pitt and UPMC roll out revolutionary way to test COVID-19 drugs
We highly encourage you to watch the above Physician Interviews.